When It Comes to Physical Activity, Resilience Outweighs Chronic Pain

By Pat Anson

It’s not uncommon for someone with chronic pain to reduce their physical activity and become more sedentary. Believing that movement will make pain worse can even lead to kinesiophobia – an irrational fear of physical activity.

But some people with chronic pain are able to remain physically active and cope with their pain – what’s known as pain resilience. Is that because they have less pain or more resilience?

A new study, published in PLOS One, suggests that resilience predicts physical activity more than pain does, and that boosting resilience should be a part of pain management. 

Researchers at the University of Portsmouth in the UK surveyed 172 adult volunteers suffering from mild-to-moderate chronic pain. Their goal was to understand how pain resilience affects the relationship between pain and movement.  

Participants were asked about their pain levels, what kind of physical activities they engaged in, and if they agreed or disagreed with a series of statements such as:

  • “I am afraid that I might injure myself accidentally.”

  • “My pain would probably be relieved if I were to exercise.”

  • “When faced with pain I avoid negative thoughts.”  

  • “When faced with pain I get back out there.”

Based on their answers, participants were given scores that ranked their resilience and kinesiophobia levels, which were then compared to their physical activity.

Researchers found that pain resilience predicts physical activity more strongly than pain intensity.

“We suspected resilience plays a major role, and this study helped confirm that,” said lead author Nils Niederstrasser, PhD, Senior Lecturer in Psychology at the University of Portsmouth.

“What we found is that it's not how much pain you're in that determines whether you stay physically active -- it's how you think about and respond to that pain, indicating that how individuals respond to and think about pain matters more than their actual pain sensitivity.”

Niederstrasser and his colleagues believe that treatments focused on building resilience could help chronic pain patients become more physically active. 

“People with greater resilience can maintain a positive attitude and push through discomfort, and this psychological factor is a better predictor of physical activity than pain intensity itself,” said Niederstrasser. “This is a significant shift from historically focusing on negative factors like fear of movement, to understanding the power of positive psychological resilience in managing chronic pain." 

This research builds on another study by Niederstrasser, which found that regular exercise and weight management can reduce pain levels, and may help prevent acute pain from becoming chronic.

Previous studies have found that being physically active boosts pain tolerance, and that light or moderate activities can have a protective effect against certain types of pain.  

Does Having Chronic Pain Mean I’ll Die Young?

By Crystal Lindell

This morning I got news that someone I knew had passed away.

I describe him as “someone I knew” because my connection to Rich is difficult to explain. He was my fiancé’s, late-mom’s, long-time boyfriend. Basically, my step-father-in-law. Ish.

After battling a bad cold, which may or may not have been COVID, he had an aneurysm and then spent a couple weeks in the ICU before passing away last night.

It’s the kind of news that’s both expected and painfully shocking.

He was too young. Just 58 years old. But his short life had been hard on him and his body. He had spent years doing manual labor and treating his pain with multiple types of medications. 

So, in retrospect, if you had asked me for a prediction, I would have told you that I never expected Rich to live to see old age.

But I didn’t really expect him to die at 58 either.

Since 2020, nine people I knew have died. Two long-time friends, my cousin, my dad, my aunt, my step-dad, my fiancé’s mom, my former boss, and now, Rich.

My fiancé Chris and I got engaged in December 2020 and he’s still my “fiancé” in large part because the onslaught of death seemed to freeze my brain in such a way that made it impossible to plan a wedding.

And now, a quarter of our would-be guest list is dead.

Many of the dead were very young. My age. All of them were too young. None of them made it to their 70s.

I can’t help but consider my own mortality. And it’s made me realize something I had been trying to avoid: People who develop severe chronic pain at 29, like I did, often don’t live long enough to be considered old. And when they do, they are the exception to the rule.

Even if the pain itself isn’t terminal, everything else will surely have an easier time taking me out. It’s not like I’m in peak disease-fighting shape. 

Not to mention all the damage that taking pills for breakfast every morning must be doing to my organs.  

The thing about the kind of nebulous chronic pain that I have is that I never got to have one of those movie-scene conversations in a doctor’s office where they clearly explain how dire my situation is. I suspect those conversations are reserved for illnesses that show up on blood work and CT Scans.

My pain has always been something only I could feel, and nobody else could see or test.

As such, my doctors have always been some mix of hopeful and dismissive about my ailment. They’d tell me that maybe I’d magically get better one day, while also telling me that they couldn’t find anything wrong with my ribs. 

And none of them have ever spoken directly to me about the many ways that chronic pain and my eventual diagnosis with Ehler-Danlos Syndrome might shorten my life expectancy. Technically, neither one is supposed to on its own. 

That doesn’t mean they can’t though. And I suspect the doctors know this, given the fact that they are willing to prescribe me the kind of opioid regime most people don’t ever go off of.

These days, I’m known among my loved ones as having “a lot of health issues,” while among my acquaintances I’m known as “the one who writes about her chronic pain online.”

So someday, when they all get the news of my death, I’m sure none of them will be too shocked. People aren’t surprised when someone like me, with a rare disease that causes chronic pain, dies young. They’re surprised when we don’t.

There was a time, in my early days with chronic pain, when I prayed for death. A time when I could not imagine spending years of my life with stabbing rib pain.

But over the years I came to accept it, and learned to manage it as much as medication would allow.

I’m 42 now, and a few years ago I started letting my gray roots grow out. 

After being surrounded by so much death, I saw them now as my silver trophy. My prize for making it to my 40s — a privilege that some of my late friends never got to experience.

How lucky am I to have lived long enough to have gray hair?

How lucky am I to be old enough for wrinkles? To have reached the age where I’m now slowly losing my ability to read small print? To be alive to complain about how hard it is to stand up, now that my body is aging.

How fortunate am I? How fantastic for me.

I can only hope that I make it much, much longer. Maybe another 42 years, if I’m truly lucky. But if not, I have faced my own mortality. I can see clearly just how fragile it is. And I’m okay with that.

I will spend my days baking, caring for loved ones, and writing. I will focus on all the things I would be focused on if I had ever gotten to have one of those somber doctor office conversations about my health. All the things that everyone realizes truly matter in life — right when they are about to run out of life themselves.

So even if I’m not OK, I will be OK.

Brittle Bones Aren’t Just a Woman’s Problem

By Paula Span, KFF Health News

Ronald Klein was biking around his neighborhood in North Wales, Pennsylvania, in 2006 and tried to jump a curb. “But I was going too slow — I didn’t have enough momentum,” he recalled.

As the bike toppled, he thrust out his left arm to break the fall. It didn’t seem like a serious accident, yet “I couldn’t get up,” he said.

At the emergency room, X-rays showed that he had fractured both his hip, which required surgical repair, and his shoulder. Klein, a dentist, went back to work in three weeks, using a cane. After about six months and plenty of physical therapy, he felt fine.

But he wondered about the damage the fall had caused. “A 52-year-old is not supposed to break a hip and a shoulder,” he said. At a follow-up visit with his orthopedist, “I said, ‘Maybe I should have a bone density scan.’”

As Klein suspected, the test showed he had developed osteoporosis, a progressive condition, increasing sharply with age, that thins and weakens bones and can lead to serious fractures. Klein immediately began a drug regimen and, now 70, remains on one.

Osteoporosis occurs so much more commonly in women, for whom medical guidelines recommend universal screening after age 65, that a man who was not a health care professional might not have thought about getting a scan. The orthopedist didn’t raise the prospect.

But about 1 in 5 men over age 50 will suffer an osteoporotic fracture in their remaining years, and among older adults, about a quarter of hip fractures occur in men.

When they do, “men have worse outcomes,” said Cathleen Colón-Emeric, a geriatrician at the Durham VA Health Care System and Duke University and the lead author of a recent study of osteoporosis treatment in male veterans.

“Men don’t do as well in recovery as women,” she said, with higher rates of death (25% to 30% within a year), disability and institutionalization. “A 50-year-old man is more likely to die from the complications of a major osteoporotic fracture than from prostate cancer,” she said.

(What’s “major”? Fractures of the wrist, hip, femur, humerus, pelvis or vertebra.)

In her study of 3,000 veterans ages 65 to 85, conducted at Veterans Affairs health centers in North Carolina and Virginia, only 2% of those assigned to the control group had undergone bone-density screening.

“Shockingly low,” said Douglas Bauer, a clinical epidemiologist and osteoporosis researcher at the University of California-San Francisco, who published an accompanying commentary in JAMA Internal Medicine. “Abysmal. And that’s at the VA, where it’s paid for by the government.”

But establishing a bone health service — overseen by a nurse who entered orders, sent frequent appointment reminders and explained results — led to dramatic changes in the intervention group, who had at least one risk factor for the condition.

Forty-nine percent of them said yes to a scan. Half of those tested had osteoporosis or a forerunner condition, osteopenia. Where appropriate, most of them began medications to preserve or rebuild their bones.

“We were pleasantly surprised that so many agreed to be screened and were willing to initiate treatment,” Colón-Emeric said.

After 18 months, bone density had increased modestly for those in the intervention group, who were more likely to stick to their drug regimens than osteoporosis patients of either sex in real-world conditions.

The study didn’t continue long enough to determine whether bone density increased further or fractures declined, but the researchers plan a secondary analysis to track that.

The results revive a longtime question: Given how life-altering, even deadly, such fractures can be, and the availability of effective drugs to slow or reverse bone loss, should older men be screened for osteoporosis, as women are? If so, which men and when?

‘It Can’t Be Osteoporosis — I’m a Guy’

Such issues mattered less when life spans were shorter, Bauer explained. Men have bigger and thicker bones and tend to develop osteoporosis five to 10 years later than women do. “Until recently, those men died of heart disease and smoking” before osteoporosis could harm them, he said.

“Now, men routinely live into their 70s and 80s, so they have fractures,” he added. By then, they have also accumulated other chronic conditions that impair their ability to recover.

With osteoporosis testing and treatment, “a man could see a clear-cut improvement in mortality and, more importantly, his quality of life,” Bauer said.

Both patients and many doctors still tend to regard osteoporosis as a women’s disease, however. “There’s a bit of a Superman idea,” said Eric Orwoll, an endocrinologist and osteoporosis researcher at Oregon Health & Science University.

“Men would like to believe they’re indestructible, so a fracture doesn’t have the implication that it should,” he added.

One patient, for example, for years resisted entreaties from his wife, a nurse, to “see someone” about his visibly rounded upper back.

Bob Grossman, 74, a retired public school teacher in Portland, blamed poor posture instead and told himself to straighten up. “I thought, ‘It can’t be osteoporosis — I’m a guy,’” he said. But it was.

Another obstacle to screening: “Clinical practice guidelines are all over the place,” Colón-Emeric said.

Professional associations like the Endocrine Society and the American Society for Bone and Mineral Research recommend that men 50 and older who have a risk factor, and all men over 70, should seek screening.

But the American College of Physicians and the U.S. Preventive Services Task Force have deemed the evidence for screening of men “insufficient.” Clinical trials have found that osteoporosis drugs increase bone density in men, as in women, but most male studies have been too small or lacked enough follow-up to show whether fractures also declined.

The task force’s position means that Medicare and many private insurers generally won’t cover screening for men who haven’t had a fracture, though they will cover care for men diagnosed with osteoporosis.

“Things have been stalled for decades,” Orwoll said.

So it may fall to older men themselves to ask their doctors about a DXA (pronounced DECKS-ah) scan, widely available at $100 to $300 out-of-pocket. Otherwise, because osteoporosis is typically asymptomatic, men (and women, who are also undertested and undertreated) don’t know their bones have deteriorated until one breaks.

“If you had a fracture after age 50, you should have a bone scan — that’s one of the key indicators,” Orwoll advised.

Other risk factors: falls, a family history of hip fractures, and a fairly long list of other health conditions including rheumatoid arthritis, hyperthyroidism and Parkinson’s disease. Smoking and excessive alcohol use increase the odds of osteoporosis as well.

“A number of medications also do a number on your bone density,” Colón-Emeric added, notably steroids and prostate cancer drugs.

When a scan reveals osteoporosis, depending on its severity, doctors may prescribe oral medications like Fosamax or Actonel, intravenous formulations like Reclast, daily self-injections of Forteo or Tymlos, or twice-annual injections of Prolia.

Lifestyle changes like exercising, taking calcium and vitamin D supplements, stopping smoking, and drinking only moderately will help but aren’t sufficient to stop or reverse bone loss, Colón-Emeric said.

Although guidelines don’t universally recommend it, at least not yet, she would like to see all men age 70 and up be screened, because the odds of disability after hip fractures are so high — two-thirds of older people will not regain their prior mobility, she noted — and the medications that treat it are effective and often inexpensive.

But informing patients and health care professionals that osteoporosis threatens men, too, has progressed “at a snail’s pace,” Orwoll said.

Klein remembers attending a seminar to instruct patients like him in using the drug Forteo. “I was the only male there,” he said.

KFF Health News is a national newsroom that produces in-depth journalism about health issues.

Cannabis Reduces Use of Opioids by Cancer Patients

By Pat Anson

The opening of cannabis dispensaries is associated with a significant decline in opioid prescriptions, according to a large new study that suggests cannabis is effective for cancer pain and reduces the need for opioids.

Researchers analyzed the health records of over 3 million commercially insured patients enrolled in Optum, the health services arm of UnitedHealth Group, and focused on those who had a cancer diagnosis.

Cancer patients who lived in states with medical or recreational cannabis dispensaries had significantly lower rates of opioid prescriptions, a lower daily supply of opioids, and fewer prescriptions per patient.

Although the study did not look at a cause-and-effect relationship between cannabis and relief from cancer pain, researchers say their findings suggest that cannabis can be an effective substitute for opioids.

Cancer pain is one of the most commonly approved conditions for medical cannabis, but there has been limited research on whether cannabis is an effective analgesic for cancer pain.

“Results of this study suggest that cannabis may serve as a substitute for opioids in managing cancer-related pain, underscoring the potential of cannabis policies to impact opioid use,” researchers reported in JAMA Health Forum.

“While opioids remain the recommended treatment for cancer pain, these patients may benefit from cannabis availability for adjuvant therapy. Further, cannabis use may reduce opioid use more among patients with cancer whose pain is not well managed with opioids or who experience negative effects of opioid use.”

Researchers believe cancer patients with lower pain levels are more likely to substitute cannabis for opioids once cannabis becomes an option.

Although opioid use by cancer patients is lower in states where medical and recreational cannabis are legal, the most significant reductions were in states with medical cannabis dispensaries. The rate of patients with opioid prescriptions was over 24% lower where there was access to a medical dispensary, while the daily supply of opioids was nearly 10% lower and the number of prescriptions per patient was over 5% lower.

Smaller reductions in opioid prescribing were associated with recreational cannabis dispensaries.   

Although cancer patients are exempt from most medical guidelines that discourage the use of opioids, many were still cutoff from opioids or had their doses reduced by doctors. A recent study found a 24% decline in opioid prescribing to Medicare patients with cancer after the CDC’s 2016 opioid guideline was released.

Last year, the FDA shutdown a special program that supplied potent fentanyl lozenges and tablets to patients suffering from severe cancer pain. The FDA decision came after it was notified by Teva Pharmaceutical that it would no longer make fentanyl lozenges or tablets.

It could become even harder for some cancer patients to obtain opioids. VA researchers recently proposed that cancer patients no longer be exempt from VA and Department of Defense guidelines that discourage the prescribing of opioids for chronic pain. The researchers said cancer patients were living longer and were at risk of “persistent opioid use.”    

Where Pain Research Is Headed and Why I’m Hopeful

By Dr. Lynn Webster

If you live with pain, you’ve probably heard promises that “something better is coming.” At this month’s Pain Therapeutics Summit in San Diego, you could see that promise taking shape. For two days, clinicians, scientists, companies and advocates compared notes on what’s working, what’s not, and what’s next.

Threaded through much of it was the National Institutes of Health’s Helping to End Addiction Long-Term (HEAL) Initiative -- an NIH-wide push launched in 2018 to accelerate better pain care and reduce opioid-related harms.

HEAL exists because of the opioid crisis; Congress gave NIH an initial $500 million in fiscal year 2018 to jump-start a coordinated research plan, and the NIH has since invested several billion dollars to keep the effort moving. In other words, HEAL is a rare silver lining: a tragedy spurring a sustained, practical response.

(The HEAL Initiative was not directly hit by any funding cuts in 2025. However, the Trump administration has proposed cutting the NIH budget by 40% next year, which could potentially impact HEAL funding.)

Since its launch, HEAL has grown into a national engine for discovery. NIH reports a cumulative investment approaching $4 billion, supporting more than 2,000 projects across all 50 states, and helping advance 40-plus new drugs and devices to FDA investigational status.

This is a sign that the pipeline is broader and closer to patients than it has been in years. Think of HEAL as scaffolding: trial networks, shared data standards, and coordinated teams that help good ideas climb faster from lab to bedside.

A decade ago, analgesic research often looked like isolated bets. Today, it feels more like a coordinated campaign. That doesn’t guarantee success, but it raises the odds that something useful will reach doctors and patients.

Just as important, what’s coming isn’t a single “miracle drug” but a wider toolkit. You’ll see more non-opioid medicines designed around the biology of different pain types; safer use of existing tools that can lower the need for higher doses when opioids are used; devices and neuromodulation approaches that calm overactive nerves or brain circuits; smarter drug delivery systems that make treatments last longer or act locally at lower doses; and digital health that captures how people actually live -- including their sleep, activity, and pain flares -- so that care decisions track real life, not just clinic visits.

The studies themselves are changing, too. Many people don’t have just one pain condition; they have overlapping problems. Newer trials are beginning to mirror that reality and to focus on outcomes you can actually experience -- walking farther, sleeping better, and participating more in life -- rather than only chasing a number on a pain scale.

Researchers are also building better signposts, such as biomarkers and other objective measures, to predict who will benefit from which therapy and who may be at risk of long-term pain after injury or surgery.

Signposts aren’t a substitute for what people tell us about their pain. In research and development, objective measures help compare treatments and identify who is most likely to benefit. Once a therapy reaches the clinic, those measures become guides, not verdicts, and should be read alongside the patient’s narrative so that care reflects how the person actually lives and feels.

HEAL has made these shifts a priority by funding large, practical datasets and endpoints that regulators and payers can use.

Here’s the clear-eyed part: many of the drugs and devices discussed at meetings like this will not make it past the investigational stage. That’s how science works. But when trials are well designed and data are shared, today’s misses can more quickly lead to tomorrow’s wins -- and the lessons won’t vanish into a file drawer.

Some analgesic candidates will cross the finish line, and even modest gains -- better sleep, fewer flares, less brain fog, or an extra hour of activity -- can change a life. Across millions of people, small wins add up to something transformative.

What does this mean if you’re living with pain right now? Expect more choices and more personalization. Conversations with your clinician may start to include options that didn’t exist a few years ago, and you may hear about clinical studies built around everyday life rather than rigid clinic schedules. If a trial is a good fit, participating in one will help move the field forward.

Most of all, there’s a reason for hope that is grounded in real progress, not hype.

None of this happened by accident. The NIH HEAL Initiative has been the engine behind much of it -- steady funding, coordination, and a focus on solutions that reach the bedside. Keeping that engine running is how promising ideas become practical relief.

Lynn R. Webster, MD, is a pain and addiction medicine specialist and serves as Executive Vice President of Scientific Affairs at Dr. Vince Clinical Research, where he consults with pharmaceutical companies.

Dr. Webster is the author of the forthcoming book, “Deconstructing Toxic Narratives -- Data, Disparities, and a New Path Forward in the Opioid Crisis,” to be published by Springer Nature. Dr. Webster is not a member of any political or religious organization.

5 Ways to Support a Loved One With Chronic Pain

By Crystal Lindell

Recently I wrote that one of the most important things you need to enjoy life with chronic pain is supportive loved ones.

But what does that look like in practice?

Below are some tips on how to realistically help loved ones who deal with chronic pain.

And if you’re the person in pain reading this, perhaps you can pass this on to your friends, family and other loved ones. Afterall, sometimes getting advice from a third party can help it land better.

Also, of course, if you have your own tips to share, we’d love to read them in the comments!

1. Keep in Touch With Them

If you care about someone with pain, maybe the most important thing you can do is to just stay in contact with them.

Having chronic pain makes it difficult to attend in-person events, but that doesn’t mean we lose the need for human connection. In fact, it just makes that need much stronger.

Sometimes friends fall off because they don’t see you as often, but other times it’s because they don’t want to have to talk to someone with chronic health issues. Those conversations can force them to face the fact that their own body is also fragile and mortal.

But if you actually care about someone, I encourage you to push past all that.

Texting and phone calls can be a lifeline for people with chronic pain — as can in-person visits.

Your interactions with them may be the majority of human interaction they have, and it can be enough to keep them going for another day.

2. Give Them Meals and Help with Chores

When I first started having chronic pain, one of my friends did one of the nicest things anyone has ever done for me – either before or since. She drove 2 hours to come visit me and then cleaned my entire apartment, including the bathroom.

It is not possible to express how grateful I was and how much of a difference that made in my ability to keep going through one of the darkest times in my life. Just having a clean space to exist was like having a weight lifted off my very painful ribs.

While healthy people can take for granted the ability to do daily household tasks like cooking meals and doing the dishes — a person with chronic pain knows how easy it is to fall behind on those things.

And when that happens, on top of the stress of dealing with a broken body, you also have to deal with a messy house. That can come with a lot of guilt and even physical discomfort.  

So, if you’re able to help them with housework in any capacity, that can also lift a truly heavy burden.

Having someone make or drop off meals once a week, or even once a month can also be a massive help. There’s also the option of sending meals with services like DoorDash or Uber Eats, or giving them food delivery gift cards.

It may seem like cooking and cleaning for someone is no big deal, but when you do it for someone with chronic pain, it can be as helpful as the best medication.

3. Don’t Be Offended If Someone Needs Rest

I need more sleep than the average person, I assume because my body is using so much energy to just exist with chronic pain. I also need more time to recover after big events like parties.

It can mean that I can’t respond to calls or text, and that I need a lot of time alone to sleep and rest.

But even my most well-meaning loved ones can take this need for rest as some sort of indictment — as though I just don’t want to be around them or to interact with them.

It’s not about them though, it’s about me and my defective body.

If someone you love has chronic pain and they need a nap, or a couple days to respond to a text, don’t take it personally. It probably just means they needed some extra rest.

4. Go to Doctor’s Appointments With Them

Chronic pain can make it more important than ever to have productive doctor appointments — but it can also make that task more difficult.

That’s why having a loved one attending doctor’s appointments with you is truly invaluable.

A second person being there to focus on what the doctor is saying and to ask questions on your behalf can mean the difference between finding treatments that actually work or not.

It also usually makes doctors take a patient more seriously when they know that a loved one is keeping tabs and will be holding them to account for their treatment outcomes.

So, if you’re able to go to doctor appointments with your loved one with chronic pain, I highly recommend doing so.  

5.  Be Accepting of their Use of Pain Medications

A lot of people face stigma for using pain medications, especially opioids.

But oftentimes, pain medication can become a point of friction between patients and loved ones, who don’t fully understand the importance of alleviating chronic pain.

Other people’s pain is always easy to endure, so it’s always easy to tell someone else that they don’t need to treat their pain.

While loved ones who say such things are usually well-meaning, those conversations can cause a lot of unnecessary stress for people in pain.

It’s best just to assume that if someone is using pain medication, then they need that pain medication.  

In the end, the best advice for supporting a loved one with chronic pain is to treat them how they want to be treated. And to accept that whatever they are going through is at least as bad as they are describing.

When you approach help from that mindset, you’ll often naturally find the best ways to support them.

Having support from loved ones can mean the difference between being able to endure a life with chronic pain or not. It’s just as important for their health as a good doctor is, and it can have just as much impact. 

It’s a Bird! It’s a Plane! It’s a Chemtrail? New Conspiracy Theory Takes Wing at HHS

By Stephanie Armour

While plowing a wheat field in rural Washington state in the 1990s, William Wallace spotted a gray plane overhead that he believed was releasing chemicals to make him sick. The rancher began to suspect that all white vapor trails from aircraft might be dangerous.

He shared his concern with reporters, acknowledging it sounded a little like “The X Files,” a science fiction television show.

Academics cite Wallace’s story as one of the catalysts behind a fringe concept that has spread among adherents to the Make America Healthy Again, or MAHA, movement and is gaining traction at the highest levels of the federal government. Its treatment as a serious issue underscores that under President Donald Trump, unscientific ideas have unusual power to take hold and shape public health policy.

The concept posits that airplane vapor trails, or contrails, are really “chemtrails” containing toxic substances that poison people and the terrain. Another version alleges planes or devices are being deployed by the federal government, private companies, or researchers to trigger big weather changes, such as hurricanes, or to alter the Earth’s climate, emitting hazardous chemicals in the process.

Several GOP lawmakers and leaders in the Trump administration remain convinced the concepts are legitimate, though scientists have sought to discredit such claims.

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to investigate climate and weather control, and is expected to create a task force that will recommend possible federal action, according to a former agency official, an internal agency memo obtained by KFF Health News, and a consultant who helped with the memo.

The plans, along with comments by top GOP lawmakers, show how rumors and conspiracy theories can gain an air of legitimacy due to social media and a political climate infused with falsehoods, some political scientists and researchers say.

“When we have low access to information or low trust in our sources of information, a lot of times we turn to our peer groups, the groups we are members of and we define ourselves by,” said Timothy Tangherlini, a folklorist and professor of information at the University of California-Berkeley. He added that the government’s investigation of conspiracy theories “gives the impression of having some authoritative element.”

HHS is expected to appoint a special government employee to investigate climate and weather control, according to Gray Delany, former head of the agency’s MAHA agenda, who said he drafted the memo. The agency has interviewed applicants to lead a “chemtrails” task force, said Jim Lee, a blogger focused on weather and climate who Delany said helped edit the memo, which Lee confirmed.

“HHS does not comment on future or potential policy decisions and task forces,” agency spokesperson Emily Hilliard said in an email.

The memo alleges that “aerosolized heavy metals such as Aluminum, Barium, and Strontium, as well as other materials such as sulfuric acid precursors, are sprayed into the atmosphere under the auspices of combatting global warming,” through a process of stratospheric aerosol injection, or SAI.

“There are serious concerns SAI spraying is leading to increased heavy metal content in the atmosphere,” the memo states.

The memo claims, without providing evidence, that the substances cause elevated heavy-metal content in the atmosphere, soil, and waterways, and that aluminum is a toxic product used in SAI linked to dementia, attention-deficit/hyperactivity disorder, asthma-like illnesses, and other chronic illnesses. The July 14 memo was addressed to White House health adviser Calley Means, who didn’t respond to a voicemail left by a reporter seeking comment.

High-level federal government officials are presenting false claims as facts without evidence and referring to events that not only haven’t occurred but, in many cases, are physically impossible, said Daniel Swain, a climate scientist at the University of California.

“That is a pretty shocking memo,” he said. “It doesn’t get more tinfoil hat. They really believe toxins are being sprayed.”

Kennedy has previously promoted debunked chemtrail theories. In May, he was asked on “Dr. Phil Primetime” about chemicals being sprayed into the stratosphere to change the Earth’s climate.

“It’s done, we think, by DARPA,” Kennedy said, referring to a Department of Defense agency that develops emerging technology for the military’s use. “And a lot of it now is coming out of the jet fuel. Those materials are put in jet fuel. I’m going to do everything in my power to stop it. We’re bringing on somebody who’s going to think only about that.”

DARPA officials didn’t return a message seeking comment.

‘This Really Matters to MAHA’

Deploying chemtrails to poison people is just one of many baseless conspiracy theories that have found traction among Trump administration health policy officials led by Kennedy, a longtime anti-vaccine activist before entering politics. He continues to promote a supposed link between vaccines and autism, as well as make statements connecting fluoride in drinking water to arthritis, bone fractures, thyroid disease, and cancer. The World Health Organization says fluoride is safe when used as recommended.

Delany, who was ousted in August from HHS, said Kennedy has expressed strong interest in chemtrails.

“This is an issue that really matters to MAHA,” said Delany, referring to the informal movement associated with Kennedy that is composed of people who are skeptical of evidence-based medicine.

The memo also alleges that “suspicious weather events have been occurring and have increased awareness of the issue to the public, some of which have been acknowledged to have been caused by geoengineering activities, such as the flooding in Dubai in 2024.” Geoengineering refers to intentional large-scale efforts to change the climate to counteract global warming.

“It is unconscionable that anyone should be allowed to spray known neurotoxins and environmental toxins over our nation’s citizens, their land, food and water supplies,” Delany’s memo states.

Scientists, meteorologists, and other branches of the federal government say these assertions are largely incorrect. Some points in the memo are accurate, including concerns that commercial aircraft contribute to acid rain.

I expected there were documents like this, but seeing it in print is nevertheless shocking. Our government is being driven by nonsensical dreck from dark corners of social media.
— David Keith, PhD, University of Chicago.

But critics say the memo builds on kernels of truth before veering into unscientific fringe theories. Efforts to control the weather are being made, largely by states and local governments seeking to combat droughts, but the results are modest and highly localized. It isn’t possible to manipulate large-scale weather events, scientists say.

Severe flooding in the United Arab Emirates in 2024 couldn’t have been caused by weather manipulation because no technology could create that kind of rainfall event, Maarten Ambaum, a meteorologist at the University of Reading who studies Gulf region rainfall patterns, said in a statement on the floods. Similar debunked claims emerged this year after central Texas experienced devastating floods.

The Government Accountability Office concluded in a 2024 report that questions remain as to the effectiveness of weather modification.

Research into changing the climate has been conducted, including work by one private company that engaged in field tests. Still, federal agencies say no ongoing or large-scale projects are underway. Study of the concept remains in the research phase. The Environmental Protection Agency says there are no large-scale or government efforts to affect the Earth’s climate.

“Solar geoengineering is not occurring via direct delivery by commercial aircraft and is not associated with aviation contrails,” the agency says on its website.

Widespread Misinformation

Misperceptions about weather, climate control, and airplane contrails extend beyond the Trump administration, scientists said.

In September, a congressional House committee hearing titled “Playing God With the Weather — A Disastrous Forecast” involved two hours of debate on the once-fringe idea. Rep. Marjorie Taylor Greene (R-Ga.), who chaired the hearing, has introduced legislation to ban weather and climate control, with a fine of up to $100,000 and up to five years in prison.

Some Democrats objected to the nature of the discussion. Rep. Melanie Stansbury (D-N.M.) accused Greene of using “the platform of Congress to proffer anti-science theories, to platform climate denialism.”

Frequently citing chemtrails, GOP lawmakers have introduced legislation in about two dozen states to ban weather modification or geoengineering. Florida passed a bill to establish an online portal so residents can report alleged violations.

“The Free State of Florida means freedom from governments or private actors unilaterally applying chemicals or geoengineering to people or public spaces,” GOP Florida Gov. Ron DeSantis said in a press statement this spring.

Meanwhile, the chemtrail conspiracy has permeated popular culture. The title track on singer Lana Del Ray’s seventh studio album is entitled “Chemtrails Over the Country Club.” Bill Maher dove into the chemtrail myth on his podcast “Club Random,” saying, “This is nuts. It’s just nuts.” And “Chemtrails,” a psychological thriller, wrapped filming in July.

Social media has given wing to the chemtrails concept and other fringe ideas involving public health. They include an outlandish belief that Anthony Fauci, who advised both Trump and President Joe Biden on the government response to the covid-19 pandemic, created the AIDS epidemic. There is no evidence of such a link, public health leaders say.

Researchers say another false belief by those on the far right holds that people who received covid vaccines could shed the virus, causing infertility in the unvaccinated. There is no evidence of such a connection, scientists and researchers say.

More severe weather events due to global warming may be driving some of the baseless theories, scientists say. And risks occur when such ideas take hold among the general population or policymakers, some public health leaders say. Climate researchers, including Swain, say they’ve received death threats.

Lee, the blogger, said he disagrees with some of the more far-fetched beliefs and is aware of the harm they can cause.

“There are people wanting to shoot down planes because they think they are chemtrails,” said Lee, adding that some believers are afraid to venture outside when plane vapor trails are visible overhead.

There is also no evidence that plane contrails cause health problems or are related to intentional efforts to control the climate, according to the EPA and other scientists.

The memo and focus at HHS on climate and weather control are alarming because they perpetuate conspiracies, said David Keith, a professor of geophysical sciences at the University of Chicago.

“It’s unmoored to reality,” he said. “I expected there were documents like this, but seeing it in print is nevertheless shocking. Our government is being driven by nonsensical dreck from dark corners of social media.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues.

3 Things You Need to Enjoy Life, Even With Chronic Pain

By Crystal Lindell

If you want to enjoy life again while also living with chronic pain, you need just three things.

1. An effective pain medication.
2. The ability to pace your activity level
3. Supportive loved ones

If you have all three of those things, it’s very possible to enjoy life while also enduring chronic pain. In fact, you could have a very happy life even with severe, debilitating pain every single day.

Unfortunately, of course, many chronic pain patients do not have all three of those things.

Even if they have access to opioids and other pain medications, they may not have the option to pace their activity levels due to things like work and parenting commitments. Or they may not have loved ones who show sympathy for what you’re going through and offer accommodations to make your life easier.

Sadly though, most doctors don’t recognize the importance of having all three things when they are treating chronic pain patients.

“Enjoying life” is usually not something doctors measure during treatments or appointments.  

Personally, I don’t think I have ever had a medical doctor ask me how much I’m enjoying life. Rather, they ask you to rate your pain level, and then either ignore you or send you off to another random specialist.

It’s why they don’t value the importance of prescribing pain medications that actually work, and why they rarely offer education for loved ones about how to better support the people in their life who have chronic pain.

It’s also why doctors rarely explain the importance of pacing your activity levels.

While I have had medical doctors tell me to quit working, I’ve had only one psychologist explain to me that instead of fully quitting, I could just cut back on some activities and plan more rest days.

In other words, stop pushing myself to the point of exhaustion before taking time to rest.

I assume that many doctors don’t grasp the concept of pacing, in large part because of their medical training. Residency scheduling makes it so that they are often working 24-hour shifts, with little time to recover before the next one.

In other words, the exact opposite of pacing.

When you have chronic pain, you can’t live that way though. Of course, technically, you can live that way, but you won’t enjoy life if you do.

If you accept the fact that you need to rest your body from time-to-time, you can actually do more activities in the long run.

However, under a capitalist system that prizes work, sometimes that is just not possible, no matter how much you want to pace yourself. In fact, the same applies to the other two things you need to enjoy life: Sometimes doctors just won’t give you pain medication and sometimes loved ones just will not support you.

There is good news though.

Even if you don’t have all three of those things, you can still find some joy in a life with chronic pain, as long as you are very stubborn and tenacious.

You just have to find alternative pain medications, like kratom or cannabis. And insist on creating a life that allows for pacing, whether that means changing jobs or moving in with family to help with daily life tasks. 

Then you have to educate your loved ones on how they can better accommodate you – and be prepared to pull back if they are mean or rude about it.

When I first developed chronic pain, I genuinely thought life was not worth living. That was more than a decade ago, and I’ve experienced countless joys since then: trips to Europe, meeting the love of my life, getting cats, and hugging my new niece.

Not to mention all the little joys, like fresh baked bread, cozy heated blankets on a cold winter night, and getting lost in a corn maze with my family.

I am very lucky to now have effective pain medication, a life that allows for pacing, and supportive loved ones. But I didn’t start that way. I rearranged my priorities to make it so. And it is possible that you can do the same.

You just have to stop trying to fight the pain, and instead learn to accept it. Then you can be free to live your life, while finding as many joys as you can along the way. 

Two-Thirds of Chronic Pain Patients Eat Comfort Foods to Help Them Cope

By Pat Anson

A slice of apple pie or a bowl of ice cream are comfort foods to many people, giving us a mood boost (not to mention a sugar rush) during times of stress, loneliness or anxiety.

For many people with chronic pain, comfort foods are also a way to cope and distract during pain flare-ups. A small study in Australia recently found that over two-thirds of people with chronic pain eat to feel better.

“People who live with pain every day need to find ways of coping. We think about medication, physiotherapy or heat packs as pain management strategies, but we don’t usually think about food in the same way. Yet two-thirds of our sample said they turned to food at least once a fortnight when pain flared,” says lead author Toby Newton-John, PhD, a clinical psychologist and Head of the Graduate School of Health at the University of Technology Sydney (UTS).

“Managing daily pain is incredibly tough, and medication often only goes so far. It’s understandable that people reach for something that feels good.”

The study, Eating to Feel Better: The Role of Comfort Eating in Chronic Pain, was recently published in the Journal of Clinical Psychology in Medical Settings.

Newton-John and his colleagues surveyed 141 adults with chronic pain, asking why they turn to food during pain flares. Given a choice of nine possible answers (and being allowed to select more than one) the results show that over half (51.8%) ate comfort foods to “give myself a pleasant experience,” followed by “distract myself” (49.6%) and “reduce my emotions” (39%).

“That was the somewhat unexpected finding,” Burton said in a press release. “Comfort eating wasn’t just for the purpose of distraction or numbing negative feelings, although those were important too. For many, eating comfort foods provided a nice experience in their day and something to look forward to. If you’re living with pain all the time, that moment of pleasure becomes a pretty powerful motivator.”

To be clear, not everyone in pain eats for distraction or pleasure. Nearly one in five (18.4%) said they tend to eat less when in pain, and a fair number said they eat as usual (11.3%), whether they’re in pain or not.

The frequency of comfort eating ran the gamut from multiple times a day (14.2%) to several times a week (19.9%), to never (18.4%).

The survey did not ask participants what foods they ate, but researchers believe pain can trigger cravings for certain foods.  

“There may also be a biological explanation. Research shows high-calorie foods can have a mild pain-relieving effect. Even in animal studies, rats in pain will seek out sugar. It seems it’s not just psychological. It's possible that there is a real analgesic property to these foods as well,” said co-author Amy Burton, PhD, a lecturer in Clinical Psychology at the UTS Graduate School of Health.

But eating for comfort comes at a cost. Nearly two thirds of participants in the study were obese (29.8%) or overweight (37.6%).  Newton-John warns that food-driven relief can become part of a vicious cycle.

“Short-term, high-calorie food makes people feel better. It reduces pain symptoms and enhances pain tolerance. Long-term, it can fuel weight gain and inflammation, which increases pressure on joints and makes pain worse; and that can trap people in a spiral that’s very hard to break,” he said.

Pain management programs usually focus on medication, physical therapy, and cognitive behavioral therapy. This research suggests a need to integrate diet and nutritional advice into pain management programs.

“We usually teach skills like relaxation, stretching exercises or how to pace activities, but we rarely talk about food in this context,” Newton-John says. “This work shows we need to help people recognise if they’re using food as a pain-management tool and give them alternatives.”

Previous studies have shown that healthy eating can reduce the severity of chronic pain. Regular consumption of vegetables, fruit, lean meat, fish, legumes/beans, and low-fat dairy products can lower pain levels and improve physical function, especially for women.

High fiber diets also reduce the risk of obesity, diabetes and cardiovascular disease, while promoting the growth of healthy bacteria in the gastrointestinal system to slow the progression of arthritis and reduce joint pain.

Ketamine Infusions Safe and Effective in Treating Chronic Pain

By Pat Anson

There are many pros and cons about the therapeutic effects of ketamine. When misused, the anesthetic drug can lead to tragedy – such as the accidental drowning death of actor Matthew Perry. And although ketamine is increasingly used to treat depression and other psychiatric disorders, the FDA “has not determined that ketamine is safe and effective for such uses.”  

Even ketamine’s use as a pain reliever has been challenged, with a recent study finding “a lot of uncertainty” about its effectiveness in treating difficult chronic pain conditions such as Complex Regional Pain Syndrome (CRPS). The authors of that study said they could find “no convincing evidence” that ketamine delivered meaningful benefits to people in pain.

A new study at the Cleveland Clinic debunks many of those findings. After following over 1,000 pain patients who received ketamine infusions, researchers concluded the infusions are safe and effective for people with chronic pain.

“We know millions of Americans are suffering from chronic pain and this research addresses critical gaps in pain management and shows a significant step forward in improving care for those patients who have otherwise exhausted all other treatment options,” said co-author Pavan Tankha, DO, medical director of Comprehensive Pain Recovery in the Cleveland Clinic’s Neurological Institute.

“The findings of the research represent a meaningful step toward improved quality of life and may accelerate access to this treatment option for patients all over the country.”

Tankha and his colleagues focused on outpatients who received low dose ketamine infusions – 0.5 mg/kg over 40 minutes for five consecutive days. Their findings, recently published in the journal Regional Anesthesia & Pain Medicine, show that over 90% of patients completed all five treatment days, demonstrating the feasibility of outpatient infusions.

Although pain relief in most patients “did not reach clinically meaningful thresholds,” up to 46% reported improvements in their pain, daily functioning, sleep, anxiety, depression, fatigue and quality of life. The improvements were sustained over 3 and 6-month follow up periods, with 80% of patients returning for additional infusions, a telling sign the treatment has benefits.

The research also demonstrated that low-dose ketamine has minimal side effects. Hallucinations, the most common side effect, were rare. No serious adverse events were reported by any patients.

“This study provides evidence for ketamine's role in chronic pain management,” said co-author Hallie Tankha, PhD, a clinical pain psychologist in the Cleveland Clinic’s Primary Care Institute.

“This is in line with my clinical experience as a pain psychologist, as patients often describe ketamine infusions as ‘life changing.' I'm encouraged by treatments that can be integrated into comprehensive care approaches, and this study demonstrates ketamine can be safely and effectively implemented in pain management settings.”

Researchers say their findings demonstrate that ketamine infusions can be part of a pain management program, when combined with behavioral therapies and patient education. The findings also give hope to millions of pain sufferers with complex conditions that have not responded to conventional treatment.

“Given the limited evidence for ketamine infusion protocols in chronic pain and existing access barriers, these real-world findings may help inform patients, payers, and healthcare systems about the potential of standardized KIT (ketamine infusion therapy),” researchers concluded.  “Our findings support integration into multidisciplinary pain centers and lay the groundwork for generating evidence needed for policy and coverage decisions.”

Although the FDA has not approved the use of ketamine in treating pain, some professional medical organizations have for certain conditions. The American Society of Anesthesiologists, American Society of Regional Anesthesia and Pain Medicine, and the American Academy of Pain Medicine have guidelines that support ketamine infusions for CRPS, chronic neuropathic pain and short-term acute pain. 

No Healthcare for Lawmakers Until Every American Has Affordable Health Insurance

By Dr. Lynn Webster

Millions of Americans stand on the brink of losing the Affordable Care Act (ACA) subsidies that make their health insurance barely affordable. Without congressional action to extend those subsidies, families will face staggering premium hikes — forcing impossible choices between health coverage and rent, groceries or prescription drugs. Many will simply go without insurance.

Meanwhile, every member of Congress continues to enjoy taxpayer-funded health insurance, untouched by the very uncertainty they allow their constituents to endure. That disparity is indefensible.

A simple idea that would change the equation is that no elected representative in Congress should receive taxpayer-funded health care until every American has access to affordable health care.

If lawmakers had to share the same risks as their constituents, the urgency of reform would shift overnight. They would feel, in their own lives, the dread of losing coverage or facing premiums that devour a paycheck. They would no longer be insulated from the hardships they are sworn to alleviate.

This is not about punishment — it is about accountability and alignment. When lawmakers see their own well-being depends on fixing the system, solutions would rise above partisan theater.

Skeptics will point out that the Constitution protects congressional compensation, and they are right. Courts might interpret health benefits as part of that protection. That is why this should not be ordinary legislation. It should be a constitutional amendment — one that makes the principle unambiguous: members of Congress cannot enjoy taxpayer-funded health coverage until the people they serve have genuine access to affordable care.

Passing an amendment is never easy. But history shows it can be done when fairness demands it. Women’s suffrage, civil rights, and lowering the voting age all required constitutional change. Each once seemed out of reach — until public demand made it unstoppable.

This proposal does not dictate the specific policy mechanism — whether through extended subsidies, a public option, or another path. It sets only the principle that Congress must solve the problem before claiming benefits for itself. That principle is fairness.

And fairness should transcend party lines. At a time when the nation feels divided on nearly every issue, the idea that our leaders should not receive what they deny their constituents ought to unite, not separate us.

Making congressional health care contingent on achieving affordable care for all Americans could become a rare opportunity to bridge political divides and move the country toward greater unity.

Healthcare is not a privilege reserved for the political class. It is a necessity for every family. Across the nation, millions face losing coverage while their elected representatives remain fully protected. The injustice is clear.

Until every American has access to affordable healthcare, no member of Congress should accept it either. If they want the benefits, they must deliver them for the people they represent.

Anything less is a betrayal of public trust.

Lynn R. Webster, MD, is a pain and addiction medicine specialist and serves as Executive Vice President of Scientific Affairs at Dr. Vince Clinical Research, where he consults with pharmaceutical companies. He is the author of the forthcoming book, “Deconstructing Toxic Narratives -- Data, Disparities, and a New Path Forward in the Opioid Crisis,” to be published by Springer Nature. Dr. Webster is not a member of any political or religious organization.

Amazon Is Putting Pharmacy Kiosks in Its Own Medical Clinics 

By Crystal Lindell

Have you ever dreamed of skipping the hassle of going to a pharmacy to pick up a prescription after you’ve seen your doctor?

Amazon wants to eliminate that extra trip by putting pharmacy kiosks — vending machines — in its One Medical clinics to dispense drugs on site. The move will increase Amazon’s growing share of U.S. pharmacy sales, at a time when many retail pharmacies are struggling. 

It also raises questions about a conflict of interest when doctors at One Medical – a wholly owned subsidiary of Amazon – steer their patients to Amazon Pharmacy kiosks to fill their prescriptions on the spot. 

In an Amazon promotional video, a One Medical doctor does just that:

Amazon is framing this as an issue of convenience that will improve the healthcare of One Medical patients, pointing out that nearly a third of all prescriptions are never filled.

"As clinicians, we see firsthand how delays in starting medication can impact treatment outcomes," Andrew Diamond, MD, Chief Medical Officer at One Medical, said in a press release. "The ability to know a patient is leaving our office with their medication in hand – especially for conditions requiring immediate treatment like infections – can make a meaningful difference in their care journey."

Starting in December, Amazon Pharmacy kiosks are being installed at One Medical clinics in the Los Angeles area, with expansion to additional clinics soon after.   

"By bringing the pharmacy directly to the point of care, we're removing a critical barrier and helping patients start their treatment when it matters most — right away," said Hannah McClellan, Vice President of Operations at Amazon Pharmacy.

To use the kiosks, patients must already have an account with Amazon Pharmacy, which requires them to provide their insurance information and other payment options. 

Once a prescription is scanned at a kiosk and the patient is verified, an Amazon pharmacist will begin to process the prescription remotely and be available to answer questions. If the prescription is approved, a robotic arm will pick out the medication from a vault inside the kiosk, label it, and drop it through a bay door for the patient to pick up.

The kiosks won’t carry controlled substances like opioids or drugs that need to be refrigerated, but that still leaves a lot of medication options for One Medical doctors to prescribe.

One Stop Shopping

Will Amazon’s doctors be incentivized to prescribe unnecessary or high-cost medications just to make extra money for their parent company?

Unfortunately, that’s not a far-fetched question to ask, given the well-known influence of pharmaceutical sales reps. The reps often give free meals, paid speaking engagements, and other financial incentives to doctors in hopes of getting them to prescribe their company’s medications. 

Amazon Pharmacy currently has a small market share compared to big chain pharmacies like CVS and Walgreens, but its home delivery system is rapidly growing and gaining in popularity. Amazon Pharmacy sales were projected to reach $1.8 billion in 2024 and some analysts say it could eventually be the leading drug store in the U.S.  

I fear that adding Amazon Pharmacy kiosks to One Medical clinics is just the first step. The company could place kiosks in other non-Amazon locations such as hospitals, medical offices, and urgent care clinics. Amazon admitted as much when it said its kiosk expansion plans include “additional One Medical offices and other locations.”

Amazon, which has a market cap of over $1 trillion, could wind up doing to pharmacies what it did to book stores 30 years ago: drive them out of business. Of course, chain pharmacies have already done a good job of doing that to themselves.

Millions of low-income and rural Americans already live in "pharmacy deserts" and have to drive long distances to fill a prescription. What will happen to them when additional pharmacies close? Or the patients who need controlled substances or refrigerated medications that the kiosks don’t dispense and Amazon won’t deliver? 

In the end, when it comes to healthcare, we should be extra cautious about the financial incentives at work and putting too much power in the hands of one company. 

Maybe the pharmacy kiosks will be convenient. Maybe Amazon’s doctors won’t prescribe unnecessary medications just to reach a kiosk sales goal. But I’m not willing to bet my health on that.

Medical Cannabis Works Best for Neuropathic Pain

By Pat Anson

Medical cannabis is most effective for managing neuropathic pain, but doesn’t work as well for migraine, headache and acute pain, according to a new report that is one of the first to look at the efficacy of cannabis in treating different types of pain conditions.

The comprehensive report by Green Health Docs, a company that connects patients with licensed medical marijuana doctors, is based in part on a recent survey of 1,450 patients who use medical cannabis.

The vast majority (86%) of those surveyed reported moderate-to-significant pain improvement. Nearly 73% said they use cannabis daily and nearly 88% said it was a long-term option for their pain management.  

The survey also found that many patients were able to reduce their use of opioids and other prescribed analgesics once they started using medical cannabis. Over a third (35%) stopped using all prescription pain medications, nearly 15% stopped some medications, and nearly 12% reduced the dosage or frequency. Only 18% reported no change in their use of pharmaceuticals.

Many respondents, especially seniors, also reported better sleep, appetite, mood, mobility and quality of life.

Researchers say medical cannabis works best for neuropathic pain, but further studies are needed to demonstrate its effectiveness in treating other types of pain.

“One of the most important findings across cannabis research is that not all types of chronic pain respond equally to cannabinoid-based therapies,” the Green Health Docs report found.

“Neuropathic pain -- caused by damage or dysfunction in the nervous system -- is one of the most studied and responsive categories for cannabis treatment. Conditions such as diabetic neuropathy, postherpetic neuralgia, and multiple sclerosis-related pain fall into this category.”

The evidence is either mixed or lacking for cannabis relieving cancer-related pain and musculoskeletal pain, which includes back pain, arthritis, fibromyalgia, and pain involving bones, joints, and connective tissue.  

Cannabis also appears to be less effective for headache or migraine pain, visceral pain in the internal organs, and surgical or acute pain.

“Taken together, these findings suggest that while medical cannabis is not a universal solution, it holds promise as a viable component of multimodal pain management—especially when other treatments prove inadequate or intolerable,” the report concluded.

38 states and Washington, D.C. have legalized medical marijuana, and “chronic pain” or “intractable pain” are two of the top qualifying conditions.

Many patients use different methods to consume medical cannabis. Tinctures, edibles and capsules are often used for steady symptom control; vapes and smoking provide faster relief from breakthrough pain; and patches and topical creams are popular for localized musculoskeletal pain.

The "entourage effect" is also an important consideration. Medical cannabis products seem to work best when they combine THC and other cannabinoids with terpenes and other compounds found in cannabis. This supports the use of full-spectrum cannabis for managing chronic pain.

Placebos Don’t Work If You Know It’s a Placebo

By Crystal Lindell

Migraine patients who knew they were getting a placebo did not get any pain relief from it.

That’s a short summary of an actual study that was published in JAMA Network Open.

And to be honest, as a pain patient and a former migraine sufferer myself, I’m annoyed that they even wasted their time and resources on this research.

So how did they reach this very obvious conclusion? They recruited 120 chronic or episodic migraine patients for a three-month trial at two headache centers in Germany. About half the participants were given an “open-label placebo” twice a day — fake pills that the patients knew were fake — along with their usual treatments. The other patients just received treatment as usual and served as a control group..

Not surprisingly, they found that the open label placebos did not reduce monthly headache days, pain intensity, or days needing rescue medication compared to the control group.

In other words, the fake pills did not work. A conclusion I could have told them before a single participant was even registered for the study.

The frustration doesn’t stop there though. The researchers then tried to salvage these results by claiming that some of the patients did have slight improvements in what they call "secondary outcomes." That includes things like quality of life, pain-related disability, and “Global Impression of Change.” The latter is a fancy way of saying they felt better.

Even though they literally got no pain relief from the placebo pills and no reduction in migraine days, the authors insist that open-label placebos (OLPs) "might have a supportive role in migraine care.”

“Although more research is needed, OLPs… could potentially be a safe and suitable complementary option for patients with migraine, especially those who prefer nonpharmacologic approaches,” said lead author Julian Kleine-Borgmann, MD, a resident in the Department of Neurology at the University Medical Center Essen.

In other words, they want to explore this ineffective line of treatment even further!

This whole study was a waste of time, and the only saving grace would have been if they saw the results and concluded that further research into fake treatments should end – so that real treatment options can be further developed.

But no, the researchers looked at these very clear results and concluded that since some patients felt slightly better, further studies are needed. 

No. Stop it.

We get it, the medical community has had little success treating migraines or developing new pain treatments. But resorting to fake pills that patients know are fake won’t help anyone – except maybe the researchers who build their careers studying it. 

In fact, it only serves to reinforce the stigma that many pain patients are just looking for attention from doctors. 

It’s not difficult to imagine doctors thinking that if fake pills work on patients who know they are fake, then clearly their pain is probably fake too.

The results of this study should prove that is not the case, but I fear that the researchers don’t seem to have fully absorbed that lesson, given the fact that they want to explore placebo treatment further.

Migraines are a very real and debilitating medical condition that can greatly impact people’s lives. Patients who suffer from them deserve very real treatments in response.

Study Finds Tramadol Not That Effective for Chronic Pain

By Pat Anson

One of the most widely prescribed opioid painkillers in the world is not that effective at relieving chronic pain and increases the risk of serious side effects such as heart disease, according to a new study.

Tramadol is a synthetic opioid used to treat moderate to severe pain. It is widely perceived as a weaker and “safer” opioid, but the new research found otherwise.

“Tramadol may have a slight effect on reducing chronic pain, while likely increasing the risk of both serious and non-serious adverse events,” wrote lead author Jehad Barakji, MD, a researcher at the Copenhagen Trial Unit at the Centre for Clinical Intervention Research in Denmark.

“The potential harms associated with tramadol use for pain management likely outweigh its limited benefits.”

Barakji and his colleagues analyzed findings from 19 clinical trials of tramadol involving over 6,500 pain patients, making it the first study to assess tramadol’s efficacy and safety across a range of chronic pain conditions.

Five of the studies looked at the impact of tramadol on neuropathic pain; nine focused on osteoarthritis; four looked at chronic lower back pain; and one focused on fibromyalgia.

The findings, published in BMJ Evidence Based Medicine, show that while tramadol eased pain, the effect was small and below what would be considered clinically effective. Tramadol also appeared to increase the risk of cardiac events, such as chest pain, coronary artery disease, and congestive heart failure. 

Use of tramadol was also associated with a higher risk of neoplasms, an excessive growth of tissue that could be an early sign of cancer. However, researchers say the evidence of a tramadol-cancer connection was “questionable” because the studies analyzed were not long enough.

Non-serious side effects caused by tramadol include nausea, dizziness, constipation and somnolence.

Tramadol is considered a weak opioid because it does not bind directly to opioid receptors in the brain like other opioids do. Many patients say tramadol gives them little or no pain relief, but it’s often the only opioid their doctor is willing to prescribe.

In 2023, over 16 million prescriptions were written for tramadol in the United States, down from 25 million prescriptions a decade earlier. Tramadol is classified as a Schedule IV controlled substance in the U.S., indicating it has a low potential for abuse and addiction compared to other opioids.

The consumer watchdog group Public Citizen unsuccessfully petitioned the FDA and DEA in 2019 to upschedule tramadol to a more restrictive Schedule II substance, saying tramadol was “an increasingly overprescribed, addictive, potentially deadly narcotic.”

Tramadol is widely abused by youths in Asia and Africa, where it is often mixed with soft drinks, energy drinks and alcohol to induce euphoria.